Principal component analysis based pre-cystectomy model to predict pathological stage in patients with clinical organ-confined bladder cancer

BJU International

Volumn 111, Issue 4 B, 2013, Pages

  Ahmadi, Hamed ^a   Mitra, Anirban P ^a   Abdelsayed, George A ^a   Cai, Jie ^a   Djaladat, Hooman ^a   Bruins, Harman M ^a   Daneshmand, Siamak ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

bladder cancer; decision support techniques; pathological stage; principal component analysis

Indexed keywords

AGE DISTRIBUTION; AGED; AREA UNDER THE CURVE; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CLINICAL EVALUATION; CYSTECTOMY; DIFFERENTIAL DIAGNOSIS; EXTRAVESICAL BLADDER CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYDRONEPHROSIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; ORGAN CONFINED BLADDER CANCER; PREDICTION; PREDICTIVE VALUE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

AGED; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; HUMANS; MALE; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PRINCIPAL COMPONENT ANALYSIS; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 84875651307     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11502.x     Document Type: Article

References (25)

1. American Cancer Society. Cancer Facts and Figures 2012. Atlanta: American Cancer Society, 2012
2. Stein JP,. Indications for early cystectomy. Semin Urol Oncol 2000; 18: 289-95
3. Morgan TM, Clark PE,. Bladder cancer. Curr Opin Oncol 2010; 22: 242-9
4. Stein JP, Lieskovsky G, Cote R, et al,. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19: 666-75
5. Sonpavde G, Sternberg CN,. Neoadjuvant chemotherapy for invasive bladder cancer. Curr Urol Rep 2012; 13: 136-46
6. Svatek RS, Shariat SF, Novara G, et al,. Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort. BJU Int 2011; 107: 898-904
7. Nguyen CT, Stephenson AJ, Kattan MW,. Are nomograms needed in the management of bladder cancer? Urol Oncol 2010; 28: 102-7
8. Karakiewicz PI, Shariat SF, Palapattu GS, et al,. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. J Urol 2006; 176 (4 Pt 1): 1354-62
9. Zaak D, Burger M, Otto W, et al,. Predicting individual outcomes after radical cystectomy: an external validation of current nomograms. BJU Int 2010; 106: 342-8
10. Shariat SF, Margulis V, Lotan Y, Montorsi F, Karakiewicz PI,. Nomograms for bladder cancer. Eur Urol 2008; 54: 41-53
11. Karakiewicz PI, Shariat SF, Palapattu GS, et al,. Precystectomy nomogram for prediction of advanced bladder cancer stage. Eur Urol 2006; 50: 1254-62
12. Fukunaga K,. Introduction to statistical pattern recognition. In, Kaufmann M, ed., Computer Science and Scientific Computing, 2nd edn. New York: Academic Press, 1990: 399-417
13. Potters L, Purrazzella R, Brustein S, Fearn P, Leibel SA, Kattan MW,. A comprehensive and novel predictive modelling technique using detailed pathology factors in men with localized prostate carcinoma. Cancer 2002; 95: 1451-6
14. Shariat SF, Palapattu GS, Karakiewicz PI, et al,. Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. Eur Urol 2007; 51: 137-51
15. Mitra AP, Skinner EC, Miranda G, Daneshmand S,. A pre-cystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer. BJU Int 2012; [Epub ahead of print]. DOI:10.1111/j.1464-410X.2012.11424.x
16. Turker P, Bostrom PJ, Wroclawski ML, et al,. Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome. BJU Int 2012; 110: 804-11
17. Meeks JJ, Bellmunt J, Bochner BH, et al,. A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer. Eur Urol 2012; 62: 523-33
18. Stimson CJ, Cookson MS, Barocas DA, et al,. Preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer. J Urol 2010; 183: 1732-7
19. Shabsigh A, Bochner BH,. Use of nomograms as predictive tools in bladder cancer. World J Urol 2006; 24: 489-98
20. Shen YJ, Huang SG,. Improve survival prediction using principal components of gene expression data. Genomics Proteomics Bioinformatics 2006; 4: 110-9
21. Bonifazzi C, Cinti MN, Vincentis GD, et al,. Principal component analysis of scintimammographic images. Phys Med 2006; 21 (Suppl. 1): 91-3
22. May M, Burger M, Brookman-May S, et al,. [Validation of pre-cystectomy nomograms for the prediction of locally advanced urothelial bladder cancer in a multicentre study: are we able to adequately predict locally advanced tumour stages before surgery?] Urologe A 2011; 50: 706-13
23. Margel D, Harel A, Yossepowitch O, Baniel J,. A novel algorithm to improve pathologic stage prediction of clinically organ-confined muscle-invasive bladder cancer. Cancer 2009; 115: 1459-64
24. Margel D, Bostrom P, Baniel J, Yossepowitch O, Zlotta A, Fleshner N,. External validation of a biomarker based pre-cystectomy algorithm to predict nonorgan confined urothelial cancers. J Urol 2012; 187: 840-4
25. Lotan Y, Capitanio U, Shariat SF, Hutterer GC, Karakiewicz PI,. Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection. BJU Int 2009; 103: 1368-74